<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
OBIO
Orchestra BioMed
$
()


  • Orchestra BioMed appoints David Pacitti to board of directors

    3/26/2024 - 08:06am
  • Orchestra BioMed announces presentations on Virtue SAB, AVIM therapy

    3/13/2024 - 08:26am
  • Orchestra BioMed announces presentation of results from study on AVIM therapy

    3/6/2024 - 08:43am
  • Orchestra BioMed presents new data on long-term effect of AVIM therapy

    2/26/2024 - 08:19am
  • Orchestra BioMed initiated with bullish view at Jefferies, here's why

    1/19/2024 - 05:06am
  • Orchestra BioMed announces initiation of BACKBEAT study of AVIM therapy

    1/8/2024 - 08:06am
  • Orchestra Biomed Holdings Inc trading resumes

    12/15/2023 - 16:00pm
  • Orchestra Biomed Holdings Inc trading halted, volatility trading pause

    12/15/2023 - 15:50pm
  • Orchestra BioMed price target lowered to $15 from $20 at Piper Sandler

    11/14/2023 - 07:33am
  • Orchestra BioMed files to sell 22.22M shares of common stock for holders

    10/10/2023 - 17:11pm
  • Orchestra BioMed granted FDA approval of IDE for BACKBEAT study

    9/19/2023 - 07:34am
  • Orchestra BioMed granted FDA approval of IDE for Virtue SAB study

    8/8/2023 - 08:39am
  • Orchestra BioMed to join Russell 3000 Index

    6/26/2023 - 08:13am
  • Orchestra BioMed appoints Andrew Taylor as CFO, succeeding Kaswan

    6/7/2023 - 08:43am
  • Orchestra BioMed expects cash to fund operations into 2026

    5/12/2023 - 09:16am
dynamic_feed Breaking News